Auflistung nach Autor "Papathanasiou, I."
Anzeige der Dokumente 1-11 von 11
-
Bone morphogenetic protein-2-induced Wnt/beta-catenin signaling pathway activation through enhanced low-density-lipoprotein receptor-related protein 5 catabolic activity contributes to hypertrophy in osteoarthritic chondrocytes
Papathanasiou, I.; Malizos, K. N.; Tsezou, A. (2012)Introduction: Events normally taking place in the terminal chondrocyte differentiation in the growth plate are also observed during osteoarthritis (OA) development, suggesting that molecules, such as Wnts and bone morphogenetic ... -
The Catabolic Role of Toll-Like Receptor 2 (TLR-2) Mediated by the NF-kappa B Pathway in Septic Arthritis
Papathanasiou, I.; Malizos, K. N.; Poultsides, L.; Karachalios, T.; Oikonomou, P.; Tsezou, A. (2011)Toll-like receptors (TLRs) are involved in mediating cell activation on stimulation with microbial components. Our objective was to investigate the role of 'PLR-2 mediated by the NF-kappa B pathway in septic arthritic ... -
Cerebellum and reading
Vlachos, F.; Papathanasiou, I.; Andreou, G. (2007)Background: Traditionally, the cerebellum has been considered to control coordinated movement. However, in recent years it has been argued that it contributes to higher cognitive functions. Objectives: This review aims to ... -
DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter
Papathanasiou, I.; Kostopoulou, F.; Malizos, K. N.; Tsezou, A. (2015)Introduction: Sclerostin (SOST), a soluble antagonist of Wnt signaling, is expressed in chondrocytes and contributes to chondrocytes' hypertrophic differentiation; however its role in osteoarthritis (OA) pathogenesis is ... -
hTERT regulation by NF-kappa B and c-myc in irradiated HER2-positive breast cancer cells
Papanikolaou, V.; Athanassiou, E.; Dubos, S.; Dimou, I.; Papathanasiou, I.; Kitsiou-Tzeli, S.; Kappas, C.; Tsezou, A. (2011)Purpose: Telomerase activity (TA), frequently observed in cancer, compensates for telomere shortening thus preventing cell senescence and conferring resistance to therapy. In the present study, we investigated the expression ... -
Low-Density Lipoprotein Receptor-Related Protein 5 (LRP5) Expression in Human Osteoarthritic Chondrocytes
Papathanasiou, I.; Malizos, K. N.; Tsezou, A. (2010)The aim of this study was to investigate the activation of the Wnt/beta-catenin pathway in osteoarthritis and the role of low-density lipoprotein receptor-related protein 5 (LRP5) in human osteoarthritic chondrocytes. The ... -
MICRORNA-33A REGULATES CHOLESTEROL SYNTHESIS AND CHOLESTEROL EFFLUX RELATED GENES IN OSTEOARTHRITIC CHONDROCYTES
Kostopoulou, F.; Malizos, K. N.; Papathanasiou, I.; Tsezou, A. (2015) -
MicroRNA-33a regulates cholesterol synthesis and cholesterol efflux-related genes in osteoarthritic chondrocytes
Kostopoulou, F.; Malizos, K. N.; Papathanasiou, I.; Tsezou, A. (2015)Introduction: Several studies have shown that osteoarthritis (OA) is strongly associated with metabolism-related disorders, highlighting OA as the fifth component of the metabolic syndrome (MetS). On the basis of our ... -
Migfilin's elimination from osteoarthritic chondrocytes further promotes the osteoarthritic phenotype via beta-catenin upregulation
Gkretsi, V.; Papanikolaou, V.; Dubos, S.; Papathanasiou, I.; Giotopoulou, N.; Valiakou, V.; Wu, C. Y.; Malizos, K. N.; Tsezou, A. (2013)Osteoarthritis (OA) is a debilitating disease of the joints characterized by cartilage degradation but to date there is no available pharmacological treatment to inhibit disease progression neither is there any available ... -
Quantitative Proteomics of Hypertrophic Chondrocytes in Osteoarthritis
Tsolis, K.; Papathanasiou, I.; Kostopoulou, F.; Gkretsi, V.; Mpei, E. S.; Kalatzaki, K.; Zerbakis, M.; Malizos, K.; Tsezou, A.; Economou, A. (2014) -
Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes
Papanikolaou, V.; Stefanou, N.; Dubos, S.; Papathanasiou, I.; Palianopoulou, M.; Valiakou, V.; Tsezou, A. (2015)Tamoxifen is a major treatment modality for estrogen receptor positive breast cancer, but the occurrence of resistance remains a problem. Recently, obesity-related leptin has been found to interfere with tamoxifen in breast ...